Vivodyne
Lab-grown human tissue plus AI for drug discovery
Grows human tissue in the lab and pairs it with AI for drug discovery and cancer research (TechCrunch, Aug 2026).
Biotech
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Vivodyne going public?
No. Vivodyne is private and has not filed to go public. There is no S-1 on file.
What is Vivodyne's valuation in 2026?
No confirmed valuation is on record for Vivodyne. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Vivodyne filed an S-1?
No public S-1 is on file for Vivodyne.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Fundraising Status
Private
Vertical Intelligence — Biotech / Gene Therapy
Biotech / Gene Therapy registry data for Vivodyne has not been collected yet — the weekly vertical sweep hasn't reached this company. Check back soon.
Talent Signal
Hiring data for Vivodyne has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.
BiotechAI
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.